Harmony Begin Period Cash Flow from 2010 to 2024

HRMY Stock  USD 34.28  0.39  1.15%   
Harmony Biosciences Begin Period Cash Flow yearly trend continues to be fairly stable with very little volatility. Begin Period Cash Flow will likely drop to about 168.8 M in 2024. Begin Period Cash Flow is the amount of cash Harmony Biosciences Holdings has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2019-03-31
Previous Quarter
333 M
Current Value
317.3 M
Quarterly Volatility
100.4 M
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Harmony Biosciences Holdings over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Harmony Biosciences' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
84.0M25.2M229.4235.1244.5168.8-70%810%2%4%-31%100%
       Timeline  

Harmony Begin Period Cash Flow Regression Statistics

Arithmetic Mean127,329,981
Geometric Mean112,577,264
Coefficient Of Variation49.36
Mean Deviation49,127,839
Median102,549,000
Standard Deviation62,853,775
Sample Variance3950.6T
Range219.3M
R-Value0.56
Mean Square Error2904.8T
R-Squared0.32
Significance0.03
Slope7,916,071
Total Sum of Squares55308.4T

Harmony Begin Period Cash Flow History

2024168.8 M
2023244.5 M
2022235.1 M
2021229.4 M
202025.2 M
201984 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Begin Period Cash Flow244.5 M168.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…